0PMJ.LSE Siemens Healthineers AG
- Market cap
- EUR 35.4B
- P/E
- 25.7x
- P/B
- -
- ROE
- 11.3%
- Dividend yield
- 2.37%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is 0PMJ.LSE undervalued?
Graham numberThe Graham number of Siemens Healthineers AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Siemens Healthineers AG fundamental analysis
No fundamental analysis for Siemens Healthineers AG yet.
Siemens Healthineers AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imagin…
Full company profileSiemens Healthineers AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Siemens Healthineers AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 13.5B | 13.7B | 13.4B | 14.5B | 14.5B | 18.0B | 21.7B | 21.7B | 22.4B | 23.4B | 22.5B |
| Gross Profit | 5.47B | 5.70B | 5.47B | 5.80B | 5.58B | 6.95B | 8.14B | 7.71B | 8.47B | 9.03B | 8.89B |
| Operating Income | 2.12B | 2.22B | 2.03B | 2.31B | 2.04B | 2.78B | 3.06B | 2.44B | 3.30B | 3.44B | 3.33B |
| EBITDA | 2.72B | 2.81B | 2.53B | 2.93B | 2.84B | 3.52B | 4.26B | 3.78B | 4.22B | 4.58B | 4.45B |
| Net Income | 1.31B | 1.38B | 1.27B | 1.57B | 1.41B | 1.73B | 2.04B | 1.51B | 1.94B | 2.14B | 2.17B |
| EPS | 1.31 | 1.38 | 1.26 | 1.57 | 1.41 | 1.56 | 1.81 | 1.34 | 1.73 | 1.91 | 1.94 |
| Balance Sheet | |||||||||||
| Total Assets | 20.3B | 21.1B | 19.8B | 21.4B | 25.1B | 41.9B | 49.1B | 46.7B | 46.1B | 44.4B | 45.7B |
| Total Liabilities | 17.9B | 17.8B | 11.1B | 11.6B | 12.6B | 25.9B | 29.2B | 28.6B | 27.8B | 26.3B | 26.6B |
| Shareholders' Equity | 2.37B | 3.28B | 8.66B | 9.77B | 12.5B | 16.0B | 19.8B | 18.1B | 18.2B | 18.0B | 19.1B |
| Cash & Short-term Investments | 223M | 195M | 546M | 920M | 656M | 1.32B | 1.44B | 1.64B | 2.68B | 2.18B | 2.36B |
| Total Debt | 9.61B | 11.0B | 4.71B | 4.53B | 5.50B | 14.3B | 16.7B | 16.7B | 16.2B | 15.1B | 15.0B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.67B | 1.73B | 1.44B | 1.50B | 1.81B | 2.78B | 2.26B | 1.81B | 2.47B | 3.08B | 2.80B |
| Capital Expenditure | 424M | 466M | 530M | 579M | 557M | 674M | 852M | 838M | 696M | 818M | 739M |
| Free Cash Flow | 1.25B | 1.26B | 910M | 919M | 1.25B | 2.11B | 1.40B | 971M | 1.77B | 2.27B | 2.06B |
| Ratios | |||||||||||
| ROE | 55.2% | 42.0% | 14.6% | 16.0% | 11.3% | 10.8% | 10.3% | 8.3% | 10.7% | 11.9% | 11.3% |
| ROA | 6.5% | 6.5% | 6.4% | 7.3% | 5.6% | 4.1% | 4.2% | 3.2% | 4.2% | 4.8% | 4.7% |
| Net Profit Margin | 9.7% | 10.1% | 9.4% | 10.8% | 9.8% | 9.6% | 9.4% | 7.0% | 8.7% | 9.2% | 9.6% |
| Debt to Equity | 4.05x | 3.36x | 0.54x | 0.46x | 0.44x | 0.89x | 0.84x | 0.92x | 0.89x | 0.83x | 0.79x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Siemens Healthineers AG dividends
- Dividend yield
- 2.37%
- Forward dividend
- -
- Payout ratio
- 49.7%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 1.07B | 0.95 | 49.7% |
| 2024 | EUR 1.06B | 0.95 | 54.7% |
| 2023 | EUR 1.07B | 0.95 | 70.6% |
| 2022 | EUR 955M | 0.85 | 46.9% |
| 2021 | 856M | 0.78 | 49.6% |
| 2020 | 798M | 0.79 | 56.6% |
| 2019 | 699M | 0.70 | 44.6% |
| 2018 | 230M | 0.23 | 18.2% |
| 2017 | 352M | 0.35 | 25.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Siemens Healthineers AG
- Insiders 67.02%
- Institutions 13.30%
- Public & others 19.68%
- Shares outstanding 1,000M
- Free float 358M
Siemens Healthineers AG company profile
- Company name
- Siemens Healthineers AG
- Ticker
- 0PMJ.LSE
- ISIN
- DE000SHL1006
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 74,300
- Fiscal year end
- September
- Address
- Siemensstr. 3, Forchheim, Germany, 91301
- Phone
- 49 9131 84 3385
- Website
- siemens-healthineers.com
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Siemens Healthineers AG management
10- Dr. Bernhard Montag Ph.D.President, CEO & Chairman of Management Board · born 1969
- Dr. Jochen Schmitz Ph.D.CFO & Member of Management Board · born 1966
- Ms. Darleen CaronChief Human Resources Officer, Labor Director & Member of Management Board · born 1964
- Ms. Elisabeth Staudinger-Leibrecht M.A.Member of Management Board · born 1970
- Ms. Astrid Kristine PlossMember of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence · born 1970
- Mr. Marc KoebernickHead of Investor Relations
- Matthias KraemerHead of Corporate Communications
- Christian KlaussnerExecutive Vice President of Finance
- Ms. Sharon J. BrackenHead of Diagnostics · born 1971
- Jerry WangHead of China